CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 48 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $61,000 | +24.5% | 58,345 | +28.6% | 0.00% | – |
| Q3 2016 | $49,000 | +444.4% | 45,385 | +272.5% | 0.00% | – |
| Q2 2016 | $9,000 | -99.6% | 12,184 | -99.4% | 0.00% | -100.0% |
| Q1 2016 | $2,299,000 | -54.1% | 1,964,900 | -3.8% | 0.00% | 0.0% |
| Q4 2015 | $5,004,000 | -14.8% | 2,042,501 | +4.3% | 0.00% | -50.0% |
| Q3 2015 | $5,875,000 | -28.0% | 1,958,285 | -0.9% | 0.00% | 0.0% |
| Q2 2015 | $8,165,000 | +920.6% | 1,976,992 | +970.0% | 0.00% | – |
| Q1 2015 | $800,000 | +42.9% | 184,773 | -2.0% | 0.00% | – |
| Q4 2014 | $560,000 | -3.9% | 188,458 | +7.3% | 0.00% | – |
| Q3 2014 | $583,000 | +45.0% | 175,660 | +10.6% | 0.00% | – |
| Q2 2014 | $402,000 | – | 158,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |